+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Skin Cancer Diagnostics Market Report 2025 - Product Thumbnail Image

Skin Cancer Diagnostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Merkel Cell Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Merkel Cell Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Non-Small Cell Lung Cancer Market by Type, Treatment Type, Distribution Channel, and Geography: Forecast up to 2027 - Product Thumbnail Image

Non-Small Cell Lung Cancer Market by Type, Treatment Type, Distribution Channel, and Geography: Forecast up to 2027

  • Report
  • July 2023
  • 223 Pages
  • Global
From
Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape - Product Thumbnail Image

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

  • Report
  • March 2023
  • 182 Pages
  • Global
From
Global Cancer Vaccine Market & Clinical Trials Outlook 2028 - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trials Outlook 2028

  • Report
  • July 2022
  • 600 Pages
  • Global
From
Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • January 2023
  • 189 Pages
  • Global
From
AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035 - Product Thumbnail Image

AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035

  • Report
  • April 2025
  • 285 Pages
  • Global
From
Active Pharmaceutical Ingredients (API) Market by Type (Innovative, Generic), Synthesis (synthetic, Biotech), Potency (HPAPI), Product (mAbs, Hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive Landscape - Global Forecast to 2030 - Product Thumbnail Image

Active Pharmaceutical Ingredients (API) Market by Type (Innovative, Generic), Synthesis (synthetic, Biotech), Potency (HPAPI), Product (mAbs, Hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive Landscape - Global Forecast to 2030

  • Report
  • October 2025
  • 578 Pages
  • Global
From
Liver Cancer Drugs Market 2025-2029 - Product Thumbnail Image

Liver Cancer Drugs Market 2025-2029

  • Report
  • April 2025
  • 236 Pages
  • Global
From
Liver Diseases Therapeutics Market - Global Forecast 2026-2030 - Product Thumbnail Image

Liver Diseases Therapeutics Market - Global Forecast 2026-2030

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1036 Pages
  • Global
From
Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 143 Pages
  • Global
From
Bispecific Antibodies Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Mechanism of Action, Target Antigen Antibody Format, Key Geographical Regions and Key Players - Product Thumbnail Image

Bispecific Antibodies Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Mechanism of Action, Target Antigen Antibody Format, Key Geographical Regions and Key Players

  • Report
  • December 2025
  • 391 Pages
  • Global
From
Next-Generation Antibody Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Next-Generation Antibody Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region - Product Thumbnail Image

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Peptide Therapeutics Market - Growth, Trends, COVID-19 Impact and Forecasts (2023-2028) - Product Thumbnail Image

Peptide Therapeutics Market - Growth, Trends, COVID-19 Impact and Forecasts (2023-2028)

  • Report
  • April 2023
  • 107 Pages
  • Global
From
Melanoma Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Melanoma Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • May 2024
  • 185 Pages
  • Global
From
Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Loading Indicator